Market by Product Type, Gender, Application, End-user, and Country Outlook | Forecast 2023-2030
According to Triton’s report, the Asia-Pacific botulinum toxin market is projected to showcase growth with a CAGR of 10.88% during the forecasted period 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries explored in the region include:
•
China
•
Japan
•
India
•
South Korea
•
ASEAN Countries
•
Australia & New Zealand
•
Rest of Asia-Pacific
Botulinum toxin is among the widely preferred
non-surgical aesthetic treatments in the region, given the rising focus on
enhancing features. Moreover, this treatment gains traction among facelift
recipients due to minimal discomfort, short recovery periods, and enduring
outcomes. On the contrary, the expanding clinical application of these
treatments has led to a surge in counterfeit and imitation products, impeding
the growth of the reviewed market across the region.
China
leads with the highest share in the region’s market. Increasing income levels and evolving spending
habits are expected to surge medical beauty treatments. The application of
botulinum toxin for medical purposes in the country involves the treatment of
conditions such as adult blepharospasm and certain types of strabismus.
Furthermore, the occurrence of facial neuropathy is increasing in China. In
this regard, with a global annual prevalence of approximately 0.003%, facial
neuropathy is more commonly observed in women, middle-aged and elderly
individuals, compared to other age groups.
On the other hand, Japan possesses a robust
healthcare system, with most medical specialists operating within the national
healthcare framework. Recently, younger dermatologists have begun exploring
uninsured aesthetic treatments. Botulinum filler procedures constitute around
27.6% of all minimally invasive treatments in the country. Globally, Japan
ranks among the top five nations in cosmetic surgical and non-surgical procedures.
Hence, the rise in aesthetic treatments accelerates the botulinum toxin
market’s expansion.
The women’s category is anticipated to see
profitable growth over the forecast period based on user demographics. This
surge is primarily attributed to the increasing trend among middle-aged women
for skin rejuvenation, coupled with a rise in the rates of aesthetic surgery.
For example, Aesthetic Society data indicates that more than 4.1 million
females underwent botulinum toxin procedures in 2020. The burgeoning interest
in cosmetic treatments arises from the aspiration for a more youthful
appearance. The market’s growth is
segmented into gender, product type, end-user, and application. Based on
gender, it is bifurcated into women and men.
The
notable companies in the market comprise Medytox Inc, Lanzhou Institute of
Biological Products Co Ltd, AbbVie Inc, Evolus Inc, Daewoong Pharmaceutical Co
Ltd, and Galderma SA.
Lanzhou Institute of Biological Products Co Ltd
is one of China’s oldest research institutes. Its primary focus encompasses the
production, research, development, and operation of a wide array of biological
products, including preventive and therapeutic items, along with diagnostic
reagents. The company houses five specialized research labs and a pilot
research lab. Strengthening its global footprint, the company has cultivated
robust collaborative relationships with renowned research institutions across
the United States, Japan, Italy, Britain, Hong Kong, etc. It is headquartered
in Gansu, China.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2023-2030
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the botulinum toxin
market revenue growth in the Asia-Pacific and its influence on the parent
market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the APAC
botulinum toxin market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
BOTULINUM TOXIN MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE BOTULINUM TOXIN MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHTS
2.2.1. GROWING
DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
2.2.2. SURGE
IN DEMAND FOR BOTULINUM TOXIN AMONG MILLENNIALS AND GEN-Z
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. PRODUCT
LAUNCHES
2.5.2. COLLABORATIONS
2.5.3. BUSINESS
EXPANSIONS & DIVESTITURES
2.6. MARKET
DRIVERS
2.6.1. SURGE
IN DEMAND FOR AESTHETIC PROCEDURES
2.6.2. RISE
IN GERIATRIC POPULATION
2.7. MARKET
CHALLENGES
2.7.1. LIMITED
REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
2.7.2. ADVERSE
EFFECTS OF BOTULINUM TOXIN
2.7.3. EMERGING
PROBLEM OF BOTULINUM TOXIN TYPE A RESISTANCE
2.8. MARKET
OPPORTUNITIES
2.8.1. EXPANSION
OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
2.8.2. RISING
MEDICAL TOURISM
2.9. ANALYST
PERSPECTIVE
3. ASIA-PACIFIC
BOTULINUM TOXIN MARKET OUTLOOK - BY PRODUCT TYPE
3.1. TYPE A
BOTULINUM TOXIN
3.2. TYPE B
BOTULINUM TOXIN
4. ASIA-PACIFIC
BOTULINUM TOXIN MARKET OUTLOOK - BY GENDER
4.1. WOMEN
4.2. MEN
5. ASIA-PACIFIC
BOTULINUM TOXIN MARKET OUTLOOK - BY APPLICATION
5.1. AESTHETIC
5.1.1. CROW’S
FEET
5.1.2. FOREHEAD
LINES
5.1.3. FROWN
LINES/GLABELLAR
5.1.4. SQUARE
JAW/MASSETER
5.1.5. OTHER
AESTHETIC APPLICATIONS
5.2. MEDICAL
5.2.1. CHRONIC
MIGRAINE
5.2.2. MUSCLE
SPASM
5.2.3. OVERACTIVE
BLADDER
5.2.4. HYPERHIDROSIS
5.2.5. OTHER
MEDICAL APPLICATIONS
6. ASIA-PACIFIC
BOTULINUM TOXIN MARKET OUTLOOK - BY END-USER
6.1. SPECIALTY
AND DERMATOLOGY CLINICS
6.2. HOSPITALS
AND CLINICS
6.3. OTHER
END-USERS
7. ASIA-PACIFIC
BOTULINUM TOXIN MARKET – BY COUNTRY OUTLOOK
7.1. ASIA-PACIFIC
7.1.1. MARKET
BY PRODUCT TYPE
7.1.2. MARKET
BY GENDER
7.1.3. MARKET
BY APPLICATION
7.1.3.1. MARKET
BY AESTHETIC
7.1.3.2. MARKET
BY MEDICAL
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. CHINA
7.1.5.1.1. CHINA
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.2. JAPAN
7.1.5.2.1. JAPAN
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.3. INDIA
7.1.5.3.1. INDIA
BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.4. SOUTH
KOREA
7.1.5.4.1. SOUTH
KOREA BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.5. ASEAN
COUNTRIES
7.1.5.5.1. ASEAN
COUNTRIES BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.6. AUSTRALIA
& NEW ZEALAND
7.1.5.6.1. AUSTRALIA
& NEW ZEALAND BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
7.1.5.7. REST
OF ASIA-PACIFIC
7.1.5.7.1. REST
OF ASIA-PACIFIC BOTULINUM TOXIN MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. ABBVIE
INC
8.1.1. OVERVIEW
8.1.2. PRODUCT
PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. EVOLUS
INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. MEDYTOX
INC
8.3.1. OVERVIEW
8.3.2. PRODUCT
PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. LANZHOU
INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
8.4.1. OVERVIEW
8.4.2. PRODUCT
PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. DAEWOONG
PHARMACEUTICAL CO LTD
8.5.1. OVERVIEW
8.5.2. PRODUCT
PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. GALDERMA
SA
8.6.1. OVERVIEW
8.6.2. PRODUCT
PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. IPSEN
PHARMA
8.7.1. OVERVIEW
8.7.2. PRODUCT
PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. HUGEL
INC
8.8.1. OVERVIEW
8.8.2. PRODUCT
PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. CANDELA
MEDICAL CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY CHALLENGES
8.10. MERZ
PHARMA GMBH & CO KGAA
8.10.1. OVERVIEW
8.10.2. PRODUCT
PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. REVANCE
THERAPEUTICS INC
8.11.1. OVERVIEW
8.11.2. PRODUCT
PORTFOLIO
8.12. US
WORLDMEDS LLC
8.12.1. OVERVIEW
8.12.2. PRODUCT
PORTFOLIO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE
1: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
TABLE
2: ASIA-PACIFIC REGULATORY FRAMEWORK FOR BOTULINUM TOXIN
TABLE
3: LIST OF PRODUCT LAUNCHES
TABLE
4: LIST OF COLLABORATIONS
TABLE
5: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE
6: LIST OF ACQUISITIONS
TABLE
7: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC
PROCEDURES
TABLE
8: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2023-2030 (IN $
MILLION)
TABLE
9: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY GENDER, 2023-2030 (IN $ MILLION)
TABLE
10: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2023-2030 (IN $
MILLION)
TABLE
11: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
TABLE
12: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
TABLE
13: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE
14: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
FIGURE
1: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE
2: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030
(IN $ MILLION)
FIGURE
3: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030
(IN $ MILLION)
FIGURE
4: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY GENDER, 2022 & 2030 (IN %)
FIGURE
5: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)
FIGURE
6: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)
FIGURE
7: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2022 & 2030 (IN %)
FIGURE
8: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE
9: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY AESTHETIC, 2022 & 2030 (IN %)
FIGURE
10: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $
MILLION)
FIGURE
11: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $
MILLION)
FIGURE
12: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030
(IN $ MILLION)
FIGURE
13: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN
$ MILLION)
FIGURE
14: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030
(IN $ MILLION)
FIGURE
15: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE
16: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY MEDICAL, 2022 & 2030 (IN %)
FIGURE
17: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $
MILLION)
FIGURE
18: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $
MILLION)
FIGURE
19: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $
MILLION)
FIGURE
20: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $
MILLION)
FIGURE
21: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS,
2023-2030 (IN $ MILLION)
FIGURE
22: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE
23: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS,
2023-2030 (IN $ MILLION)
FIGURE
24: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030
(IN $ MILLION)
FIGURE
25: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $
MILLION)
FIGURE
26: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2022 & 2030
(IN %)
FIGURE
27: CHINA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
28: JAPAN BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
29: INDIA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
30: SOUTH KOREA BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
31: ASEAN COUNTRIES BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
32: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)
FIGURE
33: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET 2023-2030 (IN $ MILLION)